{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:57:26Z","timestamp":1759939046910,"version":"3.38.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,12,15]],"date-time":"2010-12-15T00:00:00Z","timestamp":1292371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1038\/npp.2010.201","type":"journal-article","created":{"date-parts":[[2010,12,15]],"date-time":"2010-12-15T15:08:19Z","timestamp":1292425699000},"page":"735-743","source":"Crossref","is-referenced-by-count":21,"title":["Persistent Nigrostriatal Dopaminergic Abnormalities in Ex-Users of MDMA (\u2018Ecstasy\u2019): An 18F-Dopa PET Study"],"prefix":"10.1038","volume":"36","author":[{"given":"Yen F","family":"Tai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M","family":"Brignell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H Valerie","family":"Curran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Piccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,15]]},"reference":[{"key":"BFnpp2010201_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1192\/bjp.bp.106.024448","volume":"190","author":"JH Barnett","year":"2007","unstructured":"Barnett JH, Werners U, Secher SM, Hill KE, Brazil R, Masson K et al (2007). Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry 190: 515\u2013520.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2010201_CR2","volume-title":"Biological Basis of Sensation Feeling, Impulsivity and Anxiety","author":"E Barratt","year":"1983","unstructured":"Barratt E, Patton JH (1983). Impulsivity: cognitive, behavioural and psychophysiological correlates. In: Zuckerman M (ed). Biological Basis of Sensation Feeling, Impulsivity and Anxiety. Erlbaum: Hillsdale, NJ."},{"key":"BFnpp2010201_CR3","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/archpsyc.63.12.1386","volume":"63","author":"I Boileau","year":"2006","unstructured":"Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M et al (2006). Modeling sensitization to stimulants in humans: an [11C]raclopride\/positron emission tomography study in healthy men. Arch Gen Psychiatry 63: 1386\u20131395.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010201_CR4","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1002\/ana.10480","volume":"53","author":"DJ Brooks","year":"2003","unstructured":"Brooks DJ (2003). Imaging end points for monitoring neuroprotection in Parkinson's disease. Ann Neurol 53: S110\u2013S118.","journal-title":"Ann Neurol"},{"key":"BFnpp2010201_CR5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1212\/WNL.24.11.1019","volume":"24","author":"H Buschke","year":"1974","unstructured":"Buschke H, Fuld PA (1974). Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 24: 1019\u20131025.","journal-title":"Neurology"},{"key":"BFnpp2010201_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1037\/0022-3514.63.3.452","volume":"63","author":"AH Buss","year":"1992","unstructured":"Buss AH, Perry M (1992). The aggression questionnaire. J Pers Soc Psychol 63: 452\u2013459.","journal-title":"J Pers Soc Psychol"},{"key":"BFnpp2010201_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00213-004-1788-8","volume":"173","author":"MI Colado","year":"2004","unstructured":"Colado MI, O'Shea E, Green AR (2004). Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology (Berl) 173: 249\u2013263.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2010201_CR8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0022-5347(25)00317-9","volume":"241","author":"DL Commins","year":"1987","unstructured":"Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS (1987). Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241: 338\u2013345.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2010201_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00213-006-0467-3","volume":"189","author":"RL Cowan","year":"2007","unstructured":"Cowan RL (2007). Neuroimaging research in human MDMA users: a review. Psychopharmacology (Berl) 189: 539\u2013556.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2010201_CR10","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1093\/brain\/awn255","volume":"131","author":"MM de Win","year":"2008","unstructured":"de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C et al (2008). Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain 131: 2936\u20132945.","journal-title":"Brain"},{"key":"BFnpp2010201_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.neuroimage.2009.12.058","volume":"50","author":"A Egerton","year":"2010","unstructured":"Egerton A, Demjaha A, McGuire P, Mehta MA, Howes OD (2010). The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function. NeuroImage 50: 524\u2013531.","journal-title":"NeuroImage"},{"key":"BFnpp2010201_CR12","unstructured":"EMCDDA (2005). Annual Report 2005: The State of the Drugs Problem in Europe. EMCDDA: Luxembourg."},{"key":"BFnpp2010201_CR13","volume-title":"Structured Clinical Interview for DSM\u2013IV Axis I Disorders","author":"MB First","year":"1997","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JB (1997). Structured Clinical Interview for DSM\u2013IV Axis I Disorders. American Psychiatric Publishing: Washington, DC."},{"key":"BFnpp2010201_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0166-4328(02)00052-9","volume":"134","author":"G Gerra","year":"2002","unstructured":"Gerra G, Zaimovic A, Moi G, Giusti F, Gardini S, Delsignore R et al (2002). Effects of (+\/\u2212) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans. Behav Brain Res 134: 403\u2013410.","journal-title":"Behav Brain Res"},{"key":"BFnpp2010201_CR15","volume-title":"Manual of the Gibson Spiral Maze","author":"H Gibson","year":"1977","unstructured":"Gibson H (1977). Manual of the Gibson Spiral Maze. Hodder: London."},{"key":"BFnpp2010201_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/0269881106059939","volume":"20","author":"E Gouzoulis-Mayfrank","year":"2006","unstructured":"Gouzoulis-Mayfrank E, Daumann J (2006). The confounding problem of polydrug use in recreational ecstasy\/MDMA users: a brief overview. J Psychopharmacol 20: 188\u2013193.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2010201_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1124\/pr.55.3.3","volume":"55","author":"AR Green","year":"2003","unstructured":"Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019). Pharmacol Rev 55: 463\u2013508.","journal-title":"Pharmacol Rev"},{"key":"BFnpp2010201_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/archneurpsyc.1942.02290030112010","volume":"47","author":"MAX Hayman","year":"1942","unstructured":"Hayman MAX (1942). Two minute clinical test for measurement of intellectual impairment in psychiatric disorders. Arch Neurol Psychiatry 47: 454\u2013464.","journal-title":"Arch Neurol Psychiatry"},{"key":"BFnpp2010201_CR19","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/S0140-6736(95)91801-9","volume":"346","author":"J Hietala","year":"1995","unstructured":"Hietala J, Syvalahti E, Vuorio K, Rakkolainen V, Bergman J, Haaparanta M . et al (1995). Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 346: 1130\u20131131.","journal-title":"Lancet"},{"key":"BFnpp2010201_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00213-007-0837-5","volume":"194","author":"R Hoshi","year":"2007","unstructured":"Hoshi R, Mullins K, Boundy C, Brignell C, Piccini P, Curran HV (2007). Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naive controls. Psychopharmacology (Berl) 194: 371\u2013379.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2010201_CR21","doi-asserted-by":"publisher","first-page":"s13","DOI":"10.1192\/bjp.191.51.s13","volume":"51","author":"OD Howes","year":"2007","unstructured":"Howes OD, Montgomery AJ, Asselin MC, Murray RM, Grasby PM, McGuire PK (2007). Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry Suppl 51: s13\u2013s18.","journal-title":"Br J Psychiatry Suppl"},{"key":"BFnpp2010201_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/archgenpsychiatry.2008.514","volume":"66","author":"OD Howes","year":"2009","unstructured":"Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P . et al (2009). Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 66: 13\u201320.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010201_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1212\/WNL.55.2.294","volume":"55","author":"SJ Kish","year":"2000","unstructured":"Kish SJ, Furukawa Y, Ang L, Vorce SP, Kalasinsky KS (2000). Striatal serotonin is depleted in brain of a human MDMA (ecstasy) user. Neurology 55: 294\u2013296.","journal-title":"Neurology"},{"key":"BFnpp2010201_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1056\/NEJMc030208","volume":"349","author":"SM Kuniyoshi","year":"2003","unstructured":"Kuniyoshi SM, Jankovic J (2003). MDMA and parkinsonism. N Engl J Med 349: 96\u201397.","journal-title":"N Engl J Med"},{"key":"BFnpp2010201_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.20737","volume":"59","author":"AE Lang","year":"2006","unstructured":"Lang AE, Gill S, Patel NK, Lozano A, Nutt JG, Penn R et al (2006). Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol 59: 459\u2013466.","journal-title":"Ann Neurol"},{"key":"BFnpp2010201_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0014-2999(88)90717-0","volume":"152","author":"BJ Logan","year":"1988","unstructured":"Logan BJ, Laverty R, Sanderson WD, Yee YB (1988). Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. Eur J Pharmacol 152: 227\u2013234.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2010201_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/schbul\/23.1.147","volume":"23","author":"JW Maas","year":"1997","unstructured":"Maas JW, Bowden CL, Miller AL, Javors MA, Funderburg LG, Berman N et al (1997). Schizophrenia, psychosis, and cerebral spinal fluid homovanillic acid concentrations. Schizophr Bull 23: 147\u2013154.","journal-title":"Schizophr Bull"},{"key":"BFnpp2010201_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.schres.2005.06.020","volume":"78","author":"O Mason","year":"2005","unstructured":"Mason O, Linney Y, Claridge G (2005). Short scales for measuring schizotypy. Schizophr Res 78: 293\u2013296.","journal-title":"Schizophr Res"},{"key":"BFnpp2010201_CR29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00213-008-1218-4","volume":"200","author":"UD McCann","year":"2008","unstructured":"McCann UD, Szabo Z, Vranesic M, Palermo M, Mathews WB, Ravert HT et al (2008). Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+\/\u2212)3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019) users: relationship to cognitive performance. Psychopharmacology (Berl) 200: 439\u2013450.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2010201_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1192\/bjp.165.3.391","volume":"165","author":"PK McGuire","year":"1994","unstructured":"McGuire PK, Cope H, Fahy TA (1994). Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019). Br J Psychiatry 165: 391\u2013395.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2010201_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0166-4328(97)83333-5","volume":"84","author":"WP Melega","year":"1997","unstructured":"Melega WP, Raleigh MJ, Stout DB, Huang SC, Phelps ME (1997). Ethological and 6-[18F]fluoro-L-DOPA-PET profiles of long-term vulnerability to chronic amphetamine. Behav Brain Res 84: 259\u2013268.","journal-title":"Behav Brain Res"},{"key":"BFnpp2010201_CR32","volume-title":"Principles of Behavioral Neurology","author":"MM Mesulam","year":"1985","unstructured":"Mesulam MM (1985). Principles of Behavioral Neurology. F.A. Davis: Philadelphia, PA."},{"key":"BFnpp2010201_CR33","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJM199905063401817","volume":"340","author":"S Mintzer","year":"1999","unstructured":"Mintzer S, Hickenbottom S, Gilman S (1999). Parkinsonism after taking ecstasy. N Engl J Med 340: 1443.","journal-title":"N Engl J Med"},{"key":"BFnpp2010201_CR34","first-page":"1936","volume":"47","author":"AJ Montgomery","year":"2006","unstructured":"Montgomery AJ, Thielemans K, Mehta MA, Turkheimer F, Mustafovic S, Grasby PM (2006). Correction of head movement on PET studies: comparison of methods. J Nucl Med 47: 1936\u20131944.","journal-title":"J Nucl Med"},{"key":"BFnpp2010201_CR35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/10673220216223","volume":"10","author":"AG Montoya","year":"2002","unstructured":"Montoya AG, Sorrentino R, Lukas SE, Price BH (2002). Long-term neuropsychiatric consequences of \u2018ecstasy\u2019 (MDMA): a review. Harv Rev Psychiatry 10: 212\u2013220.","journal-title":"Harv Rev Psychiatry"},{"key":"BFnpp2010201_CR36","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1471-4159.1990.tb02358.x","volume":"54","author":"JF Nash","year":"1990","unstructured":"Nash JF, Meltzer HY, Gudelsky GA (1990). Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens. J Neurochem 54: 1062\u20131067.","journal-title":"J Neurochem"},{"key":"BFnpp2010201_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2009.06.009","volume":"204","author":"S Nikolaus","year":"2009","unstructured":"Nikolaus S, Antke C, Muller HW (2009). In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders. Behav Brain Res 204: 32\u201366.","journal-title":"Behav Brain Res"},{"key":"BFnpp2010201_CR38","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/0028-3932(90)90137-D","volume":"28","author":"AM Owen","year":"1990","unstructured":"Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW (1990). Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 28: 1021\u20131034.","journal-title":"Neuropsychologia"},{"key":"BFnpp2010201_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0028-3932(94)00098-A","volume":"33","author":"AM Owen","year":"1995","unstructured":"Owen AM, Sahakian BJ, Semple J, Polkey CE, Robbins TW (1995). Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 33: 1\u201324.","journal-title":"Neuropsychologia"},{"key":"BFnpp2010201_CR40","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/jcbfm.1985.87","volume":"5","author":"CS Patlak","year":"1985","unstructured":"Patlak CS, Blasberg RG (1985). Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5: 584\u2013590.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2010201_CR41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/archpsyc.1986.01800070059008","volume":"43","author":"D Pickar","year":"1986","unstructured":"Pickar D, Labarca R, Doran AR, Wolkowitz OM, Roy A, Breier A et al (1986). Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment. Arch Gen Psychiatry 43: 669\u2013676.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010201_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cca.2006.02.019","volume":"370","author":"F Pragst","year":"2006","unstructured":"Pragst F, Balikova MA (2006). State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta 370: 17\u201349.","journal-title":"Clin Chim Acta"},{"key":"BFnpp2010201_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.genhosppsych.2008.01.007","volume":"30","author":"J Ramirez-Bermudez","year":"2008","unstructured":"Ramirez-Bermudez J, Ruiz-Chow A, Perez-Neri I, Soto-Hernandez JL, Flores-Hernandez R, Nente F et al (2008). Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium. Gen Hosp Psychiatry 30: 337\u2013343.","journal-title":"Gen Hosp Psychiatry"},{"key":"BFnpp2010201_CR44","volume-title":"A Manual for the Administration and Scoring of the Trail Making Test","author":"RM Reitan","year":"1959","unstructured":"Reitan RM (1959). A Manual for the Administration and Scoring of the Trail Making Test. Indiana University Press: Indianapolis, USA."},{"key":"BFnpp2010201_CR45","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/S0140-6736(01)06888-X","volume":"358","author":"L Reneman","year":"2001","unstructured":"Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB et al (2001). Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358: 1864\u20131869.","journal-title":"Lancet"},{"key":"BFnpp2010201_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00213-001-0930-0","volume":"159","author":"L Reneman","year":"2002","unstructured":"Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning B et al (2002). Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study\u2013preliminary report. Psychopharmacology (Berl) 159: 335\u2013340.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2010201_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/0269881106061515","volume":"20","author":"L Reneman","year":"2006","unstructured":"Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ Neuroimaging findings with MDMA\/ecstasy: technical aspects, conceptual issues and future prospects. J Psychopharmacol, (2006) 20: 164\u2013175.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2010201_CR48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1192\/bjp.bp.108.050344","volume":"194","author":"S Selvaraj","year":"2009","unstructured":"Selvaraj S, Hoshi R, Bhagwagar Z, Murthy NV, Hinz R, Cowen P . et al (2009). Brain serotonin transporter binding in former users of MDMA (\u2018ecstasy\u2019). Br J Psychiatry 194: 355\u2013359.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2010201_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1192\/bjp.175.1.63","volume":"175","author":"DM Semple","year":"1999","unstructured":"Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC (1999). Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (\u2018ecstasy\u2019) users. Br J Psychiatry 175: 63\u201369.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2010201_CR50","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1097\/00004647-199911000-00003","volume":"19","author":"FE Turkheimer","year":"1999","unstructured":"Turkheimer FE, Brett M, Visvikis D, Cunningham VJ (1999). Multiresolution analysis of emission tomography images in the wavelet domain. J Cereb Blood Flow Metab 19: 1189\u20131208.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2010201_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000117969","volume":"9","author":"K Wesnes","year":"1983","unstructured":"Wesnes K, Warburton DM (1983). Effects of smoking on rapid information processing performance. Neuropsychobiology 9: 223\u2013229.","journal-title":"Neuropsychobiology"},{"key":"BFnpp2010201_CR52","first-page":"1135","volume":"45","author":"AL Whone","year":"2004","unstructured":"Whone AL, Bailey DL, Remy P, Pavese N, Brooks DJ (2004). A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study. J Nucl Med 45: 1135\u20131145.","journal-title":"J Nucl Med"},{"key":"BFnpp2010201_CR53","volume-title":"The Rivermead Behavioural Memory Test","author":"B Wilson","year":"1985","unstructured":"Wilson B, Cockburn J, Baddeley A (1985). The Rivermead Behavioural Memory Test. Thames Valley Text: Reading, UK."},{"key":"BFnpp2010201_CR54","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nm0696-699","volume":"2","author":"JM Wilson","year":"1996","unstructured":"Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM et al (1996). Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2: 699\u2013703.","journal-title":"Nat Med"},{"key":"BFnpp2010201_CR55","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1136\/bmj.302.6785.1150-b","volume":"302","author":"AR Winstock","year":"1991","unstructured":"Winstock AR (1991). Chronic paranoid psychosis after misuse of MDMA. BMJ 302: 1150\u20131151.","journal-title":"BMJ"},{"key":"BFnpp2010201_CR56","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1046\/j.0022-3042.2002.00758.x","volume":"80","author":"J Yuan","year":"2002","unstructured":"Yuan J, Cord BJ, McCann UD, Callahan BT, Ricaurte GA (2002). Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity. J Neurochem 80: 960\u2013969.","journal-title":"J Neurochem"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2010201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2010201","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2010201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T20:59:41Z","timestamp":1740776381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2010201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,15]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["BFnpp2010201"],"URL":"https:\/\/doi.org\/10.1038\/npp.2010.201","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"type":"print","value":"0893-133X"},{"type":"electronic","value":"1740-634X"}],"subject":[],"published":{"date-parts":[[2010,12,15]]}}}